For instance, IGF-1R inhibitors have been investigated for lung cancer treatment, blocking the activation of the IGF-1R signaling pathway and inhibiting the proliferation and invasion of lung cancer cells (58, 59). Here, IGF1R is linked to lung carcinoma.